Plain-English translation of NCT06174038 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
EARHLI is a one-year study testing whether prescription hearing aids can help slow memory decline in people who have both hearing loss and early signs of cognitive trouble. Researchers want to understand whether improving hearing might also protect the brain and reduce the risk of dementia. Half of the 150 participants will receive hearing aids right away with professional fitting and support, while the other half will join a health education program and receive free hearing aids at the end of the year.
Scientists have noticed that hearing loss and memory problems often occur together as people age, and they suspect that untreated hearing loss may put extra stress on the brain. This study is designed to find out whether treating hearing loss early—before serious memory loss develops—might be one way to protect thinking skills and lower the risk of Alzheimer's disease.
You likely qualify if…
You likely don't qualify if…
You will visit Columbia University Irving Medical Center for assessments at the start, 6 months, and 12 months. All participants receive hearing tests and blood tests, and about half will have two brain MRI scans. If you are randomly chosen for the hearing aid group, you will have 4 sessions over 8 weeks (each about 75 minutes) for professional hearing aid fitting and support, plus a follow-up session later. If you are in the health education group, you will attend the same number and length of sessions learning about healthy aging, and you'll get free hearing aids at the end of the year. Throughout the study, you may receive check-in phone calls to keep you on track.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States